Bid Publish Date
18-Feb-2026, 3:36 pm
Bid End Date
05-Mar-2026, 4:00 pm
Location
Progress
Quantity
16000
GEM invites bids for pharmaceutical products and packaging under the Central Delhi, Delhi procurement corridor. The scope includes medicine name, dosage form, strength, and primary packing type with pack size per strip; suppliers must provide a valid drug manufacturing license under the Drugs and Cosmetic Act and related test reports. The tender emphasizes compliance with uploaded special terms, shelf-life data, and mandatory certifications. Key differentiators include Make in India authorization and integrity pact compliance, with vendor flexibility on quantity as per clause. The project requires hospital-grade supply marked for hospital use only and includes disclosure of packaging specifics for accurate lot identification. This opportunity targets established drug suppliers with regulatory credentials and packaging capabilities in a centralized government framework.
MSME/NSIC EMD exemption possible with certificate
Make in India authorization certificate required
Integrity Pact and hospital supply marking mandatory
Option clause allows ±50% quantity variation at contract
Delivery period linked to last original delivery date; extended period rules apply
Payment terms to be as per buyer policy; typical Govt terms may include milestone or after delivery subject to submission of required documents and compliance certificates
Delivery period commences from last date of original delivery order; extended delivery time calculated by (additional quantity/original quantity) × original delivery period, minimum 30 days
Penalties apply for late delivery; LD rates and calculation method to be confirmed in contract, with minimums aligned to policy
Proven experience delivering medicines or hospital supplies to Govt/PSU or large private organizations
Valid GST, PAN, and drug manufacturing license under Drugs and Cosmetic Act
Must provide Make in India authorization and signed Integrity Pact
Main Document
CATALOG Specification
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
| Category | Specification | Requirement |
|---|---|---|
| PRODUCT INFORMATION | Medicine Name | Metoclopramide |
| PRODUCT INFORMATION | Dosage Form | Tablet |
| PRODUCT INFORMATION | Strength | 10 mg |
| PRODUCT INFORMATION | Compliance to uploaded Special Terms and Conditions | Yes |
| PACKAGING | Type of primary packing | Blister |
| PACKAGING | Primary pack size (Number of tablets per strip/blister) | 10 |
| CERTIFICATIONS & REPORTS | Availability of valid drug manufacturing license issued from the competent authority defined under Drugs and Cosmetic Act and Rules there under as amended till date | Yes |
| CERTIFICATIONS & REPORTS | Submission of all necessary certifications, licenses and test reports to the buyer as per buyer requirement at the time of bid submission and along with supplies | Yes |
| SHELF LIFE | Shelf life in months from the date of manufacture | 24, 36 Or higher |
Discover companies most likely to bid on this tender
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates for prior Govt/PSU/private sector supply
EMD submission document (or MSME/NSIC exemption certificate)
Make in India authorization certificate
Drug manufacturing license under Drugs and Cosmetic Act
Integrity Pact signed copy
Technical bid documents and OEM authorizations (if applicable)
Key insights about DELHI tender market
Bidders must meet eligibility criteria including valid drug manufacturing license, GST, PAN, and experience with Govt/PSU supply. Provide Make in India authorization and signed Integrity Pact. Submit EMD (or MSME exemption) and all test reports with bid; ensure IS 550 packaging compliance and hospital-use labeling.
Submit GST certificate, PAN card, drug manufacturing license under Drugs and Cosmetic Act, MSME/NSIC exemption certificate if applicable, Make in India authorization, Integrity Pact, experience certificates, financial statements, and OEM authorizations; attach test reports and packaging details per tender terms.
Primary packing type and pack size per strip/blister must be specified; shelf life must be stated in months from manufacture. Ensure IS 550 compliant packaging standards and hospital-use labeling; provide exact months and verification dates in the bid.
EMD exemption is available for eligible MSME or NSIC bidders; must enclose the exemption certificate with bid. Otherwise, submit the EMD as per tender guidelines and ensure payment method aligns with portal requirements.
Delivery schedule is tied to the last date of the original delivery order; if quantities vary up to 50%, the extended period is calculated as (additional quantity/original quantity) × original period, minimum 30 days, with contract terms maintaining contracted rates.
Provide the current drug manufacturing license under the Drugs and Cosmetic Act, test reports, and Make in India authorization. Also include Integrity Pact and ISI/ISO-related certifications if specified by the buyer, ensuring all documentation is uploaded at bid submission.
Cross-check that the medicine packaging conforms to IS 550 standards, with explicit pack sizes and strip configurations. Include compliance certificates and test reports demonstrating IS 550 alignment, and ensure hospital-use labeling as per buyer requirements.
Payment terms follow the buyer's policy; suppliers should expect terms aligned with Govt procurement, potentially milestone-based or post-delivery. Ensure all required documents (certificates, license, and test reports) are submitted to enable timely processing.
Sign up now to access all documents
Main Document
CATALOG Specification
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS